Etiology and Main Pathogenetic Mechanisms
The pathogenesis of hypercalcemia is based on an imbalance between the intake, distribution, and excretion of calcium. Several leading mechanisms are distinguished:
- Excessive intake. Occurs with inappropriate administration of calcium salts, including parenteral solutions (e.g., CaCl2).
- Enhanced intestinal absorption. Directly related to increased concentration or effects of calcitriol. This hormone actively stimulates the transport of ions from the small intestinal lumen into the bloodstream.
- Decreased renal excretion. Retention of Ca2+ ions in the blood is often driven by endocrine disorders. These include excess parathyroid hormone (PTH) (due to adenoma or parathyroid hyperplasia) and calcitonin deficiency. Vitamin D toxicity also plays a major role by enhancing intestinal absorption and provoking massive bone resorption.
- Redistribution from tissues to blood. A prime example is acidosis, in which hydrogen ions (H+) displace calcium from the bone matrix. A similar mechanism is characteristic of diabetes mellitus, renal failure, prolonged immobilization, and certain malignancies.
- Increased ionization. Acidosis can increase the fraction of free (ionized) serum calcium while total calcium formally remains within the normal range.
- Tissue destruction. One of the most common causes is the growth and subsequent breakdown of malignant neoplasms, accompanied by a massive release of ions into the bloodstream.
Clinical Manifestations and Complications
Symptoms of hypercalcemia directly depend on the serum calcium concentration. The threshold for the appearance of initial clinical signs is typically 11–12 mg/dL. Prior to reaching this level, the condition may be completely asymptomatic, although micro-calculi may already be forming in the kidneys during this latent period.
The classic clinical picture includes several main groups of disorders:
- Gastrointestinal symptoms. Patients experience non-specific yet debilitating symptoms: prominent nausea, vomiting, anorexia, and persistent constipation. Severe abdominal pain may occur, and critical cases can progress to ileus.
- Renal involvement. Excess calcium filtered by the kidneys causes hypercalciuria. This inevitably leads to nephrolithiasis and urolithiasis. Chronic progression can result in severe renal failure.
- Bone changes. Because calcium is actively leached from bone stores, osteoporosis rapidly progresses, increasing the risk of fractures.
- Neuropsychiatric disorders. The toxic effect of excessive ions on the nervous system causes a wide spectrum of disturbances. When concentrations exceed 3.0 mmol/L, the condition becomes life-threatening with a high risk of coma.
Management and Treatment Approaches
Therapeutic tactics for hypercalcemia require a multimodal approach directed at both the underlying cause and pathogenetic mechanisms:
- Etiotropic therapy. The foundation of treatment is identifying and eliminating the primary disease or pathological process that triggered the imbalance.
- Stimulation of excretion (forced diuresis). To rapidly lower blood calcium, intravenous infusion of isotonic sodium chloride solution is administered. This procedure must be combined with diuretics to effectively excrete excess calcium in the urine.
- Inhibition of bone resorption. To halt the release of calcium from the bone matrix, osteoclast activity must be suppressed. Specific medications are prescribed for this purpose: bisphosphonates, estrogens, calcitonin, and gallium nitrate. An important therapeutic benefit of these drugs is that they not only halt demineralization but also promote active remineralization (restoration of bone density).